Projects funded by the NCN
Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmacological target the disease.
2013/09/D/NZ7/02520
Keywords:
depression antidepressants epigenetic changes MeCP2 olfactory bulbectomy chronic mild stress
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_7: Signal transduction
- NZ4_4: Pathophysiology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii PAN
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 5 - announced on 2013-03-15
Amount awarded: 479 040 PLN
Project start date (Y-m-d): 2014-02-17
Project end date (Y-m-d): 2019-02-16
Project duration:: 60 months (the same as in the proposal)
Project status: Project settled